(Q33208276)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

DNA vaccines and their application against parasites--promise, limitations and potential solutions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Terence W Spithill

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Adam Rainczuk

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Nicholas Kennedy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

Biotechnology Annual Review

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

189-236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

Direct gene transfer into mouse muscle in vivo

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Therapy of tuberculosis in mice by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

High-level generation of polyclonal antibodies by genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Nucleic acid vaccines against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Assuring the safety and efficacy of DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA vaccines for parasitic infections

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

1 reference

7 January 2021

Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Direct transfection and activation of human cutaneous dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Drug-inducible, dendritic cell-based genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Toll-like receptor 9, CpG DNA and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Expression library immunization protects mice against a challenge with virulent rodent malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Trans-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunogenicity of an optimized Entamoeba histolytica gal-lectin DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Construction and immunogenicity of a codon-optimized Entamoeba histolytica Gal-lectin-based DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Therapy of murine cutaneous leishmaniasis by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Optimization of DNA vaccination against cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA vaccination with the serine rich Entamoeba histolytica protein (SREHP) prevents amebic liver abscess in rodent models of disease

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

The regulation of immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

In the belly of the beast: subversion of macrophage proinflammatory signalling cascades during Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Cryptosporidiosis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Cryptosporidiosis: epidemiology and impact

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Cryptosporidiosis: biology, pathogenesis and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Current status of malaria and potential for control

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

The pathogenic basis of malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Multi-gene vaccination against malaria: A multistage, multi-immune response approach

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Vaccines against asexual stage malaria parasites.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Multi-plasmid DNA vaccination avoids antigenic competition and enhances immunogenicity of a poorly immunogenic plasmid

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A multilateral effort to develop DNA vaccines against falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Development of a malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Naturally exposed populations differ in their T1 and T2 responses to the circumsporozoite protein of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

1 reference

7 January 2021

A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony sti

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Characterization of antibody responses to a Plasmodium falciparum blood-stage antigen induced by a DNA prime/protein boost immunization protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Expression library immunization to identify protective antigens from Cowdria ruminantium

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection against mycoplasma infection using expression-library immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Specific cellular and humoral immune response in Balb/c mice immunised with an expression genomic library of Trypanosoma cruzi.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Evaluation of SIV library vaccines with genetic cytokines in a macaque challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

ELI's coming: expression library immunization and vaccine antigen discovery

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: immunogenicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

From genomics to vaccines: malaria as a model system

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Specificity of the protective antibody response to apical membrane antigen 1

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunization of animals: from DNA to the dinner plate

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Particle-mediated DNA immunization of cattle confers long-lasting immunity against bovine herpesvirus-1

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection of pigs against Aujeszky's disease by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encoding a Cryptosporidium parvum antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Nucleic acid vaccination of sheep: Use in combination with a conventional adjuvanted vaccine against Taenia ovis

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Laboratory and field evaluation of Schistosoma japonicum DNA vaccines in sheep and water buffalo in China

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Field testing of Schistosoma japonicum DNA vaccines in cattle in China

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A comparison of DNA vaccines expressing the 45W, 18k and 16k host-protective antigens of Taenia ovis in mice and sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Technical and regulatory hurdles for DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Electroporation improves the efficacy of DNA vaccines in large animals

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Direct gene transfer into nonhuman primate myofibers in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunization of livestock with DNA vaccines: current studies and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Efficacy of DNA vaccination by different routes of immunisation in sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Induction of immune responses by DNA vaccines in large animals

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Priming by DNA immunization augments T-cell responses induced by modified live bovine herpesvirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Different patterns of immune responses but similar control of a simian-human immunodeficiency virus 89.6P mucosal challenge by modified vaccinia virus Ankara (MVA) and DNA/MVA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Rapid appearance of secondary immune responses and protection from acute CD4 depletion after a highly pathogenic immunodeficiency virus challenge in macaques vaccinated with a DNA prime/Sendai virus vector boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Prior DNA immunization enhances immune response to dominant and subdominant viral epitopes induced by a fowlpox-based SIVmac vaccine in long-term slow-progressor macaques infected with SIVmac251

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Development of a DNA-MVA/HIVA vaccine for Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Genetic adjuvants for DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbre

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: effects on papilloma formation and regression in the cottontail rabbit papillomavirus--rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2. results from a phase Ib clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginale

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Bm86 antigen induces a protective immune response against Boophilus microplus following DNA and protein vaccination in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Induction of Broad and Potent Anti-Human Immunodeficiency Virus Immune Responses in Rhesus Macaques by Priming with a DNA Vaccine and Boosting with Protein-Adsorbed Polylactide Coglycolide Microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Gene gun immunization in a preclinical model is enhanced by B7 targeting.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

CD40 ligand (CD154) enhances the Th1 and antibody responses to respiratory syncytial virus in the BALB/c mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Targeting with bovine CD154 enhances humoral immune responses induced by a DNA vaccine in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhancement of DNA vaccine potency by electroporation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Biological activity of immunostimulatory CpG DNA motifs in domestic animals

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: Adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A Toll-like receptor recognizes bacterial DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Differential signaling by CpG DNA in DCs and B cells: not just TLR9

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Dendritic cell discoveries provide new insight into the cellular immunobiology of DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Delivery of a heterologous antigen by a registered Salmonella vaccine (STM1).

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

The role of dendritic cells during Salmonella infection

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

A recombinant Salmonella typhimurium vaccine strain is taken up and survives within murine Peyer's patch dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Dendritic cells shuttle microbes across gut epithelial monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Migration of Salmonella typhimurium --harboring bone marrow--derived dendritic cells towards the chemokines CCL19 and CCL21.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Toll-like receptor 4 is not required for the full maturation of dendritic cells or for the degradation of Gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1387-2656%2804%2910007-0

7 January 2021

10.1016/S1387-2656(04)10007-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15504707%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference